7
Views
4
CrossRef citations to date
0
Altmetric
Research Article

No microheterogenous changes of plasma C-reactive protein found in man during various diseases

Pages 293-304 | Published online: 08 Jul 2009

REFERENCES

  • Fischer CL, Gill C, Forrester MG, Nakamura R. Quantitation of "acute-phase proteins" postopera-tively. Am J Clin Pathol 1976; 66: 840–6.
  • Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (Pentaxins) and Serum Amyloid A Protein. Adv Immunol 1983; 34: 141–211.
  • Mustard RA, Bohnen JMA, Haseeb S, Kasina R. C-reactive protein levels predict postoperative septic complications. Arch Surg 1987; 122: 69–73.
  • Ballou SP, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med 1992; 37: 313–36.
  • Lasson A, Berling R, Göransson J. Plasma CRP-levels in the diagnosis of postoperative complications. Surg Res Commun 1992; 12: 203— 11.
  • Stahl W, Singh A, Marcus M. Responses of opsonic substances to major trauma and sepsis. Crit Care Med 1985; 13: 779–82.
  • Waydhas C, Nast-Kolb D, Jochum M, Trupka A, Lenk S, Fritz H, Duswald KH, Schweiberer L. Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg 1992; 127: 460–7.
  • Schentag JJ, O'Keeffe D, Marmion M, Wels PB. C-reactive protein as an indicator of infection relapse in patients with abdominal sepsis. Arch Surg 1984; 119: 300–4.
  • Lasson A, Delshammmar M, Ohlsson K. Severity scoring and prediction of complications in perito-nitis. Surg Res Commun 1988; 3: 327–34.
  • Mayer AD, McMahon MJ, Bowen M, Cooper EH. C-reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol 1984; 37: 207 — 11.
  • Bfichler M, Malfertheiner P, Schoetensack C, Uhl W, Scherbaum W, Beger HG. Wertigkeit biochemischer und bildgebender Verfahren für Diagnose und Prognose der akuten Pankreatitis-Ergebniss einer Prospektiven Klinischen Untersu-chung. Z Gastroenterologie 1986; 24: 100–9.
  • Berling R, Lasson A, Axelsson L, Hjelmqvist H, Ohlsson K. Plasma CRP levels in the prediction of complications during acute pancreatitis. Surg Res Commun 1990; 8: 241–9.
  • Göransson J, Lasson A. Plasma levels of C-reactive protein in the diagnosis of acute abdom-inal disease. Surg Res Commun 1991; 11: 107— 18.
  • Chi CH, Shiesh SC, Chen KW, Wu MH, Lin XZ. C-reactive protein for the evaluation of acute abdominal pain. Am J Emerg Med 1996; 14: 254–6.
  • Haupt W, Hohenberger W, Mueller R, Klein P, Christou NV. Association between preoperative acute phase response and postoperative complica-tions. Eur J Surg 1997; 163: 39–44.
  • Göransson J, Jonsson S, Lasson A. Screening of concentrations of C-reactive protein and various plasma protease inhibitors preoperatively for the prediction of postoperative complications. Eur J Surg 1998; 164: 89–101.
  • Waydhaus C, Nast-Kolb D, Trupka A, Zettl R, Kick M, Wiesholler J, Schweiberer L, Jochum M. Posttraumatic inflammatory response, secondary operations, and late multiple organ failure. J Trauma 1996; 40: 624–31.
  • Cooper EH, Stone J. Acute phase reactant proteins in cancer. Avd Cancer Res 1979; 30: 1–14.
  • Drahovsky D, Dunzendorfer U, Ziegenhagen G, Drahovsky M, Kellen JA. Re-evaluation of C-reactive protein in cancer sera by radioimmuno-assay and radial immunodiffusion. Oncology 1981; 38: 286–91.
  • Raynes JG, Cooper EH. Comparison of serum amyloid A protein and C-reactive protein con-centrations in cancer and non-malignant disease. J Clin Pathol 1983; 36: 798–803.
  • Weinstein PS, Skinner M, Sipe JD, Likich JJ, Zamchek N, Cohen AS. Acute phase proteins or tumor markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol 1984; 19: 193–8.
  • Bfichler M, Malfertheiner P, Uhl W, Beger HG. C-reaktives Protein als Entzfindungs- und Nekro-semarker in der Gastroenterologi. Med Klin 1987; 82: 180–5.
  • De Mello J, Struthers L, Turner R, Cooper EH, Giles GR. Multivariate analyses as aids to diagnosis and assessment of prognosis in gastro-intestinal cancer. Br J Cancer 1983; 48: 341–8.
  • Durdey P, Williams NS, Brown DA. Serum carcinoembryonic antigen and acute phase reac-tant proteins in the preoperative detection of fixation of colorectal tumours. Br J Surg 1984; 71: 881 — 4.
  • Göransson J, Jonsson S, Lasson A. Preoperative plasma levels of C-reactive protein, albumin and various plasma protease inhibitors for the pre-operative assessment of operability and recurrence in cancer surgery. Eur J Surg Oncol 1996; 22: 607— 17.
  • Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Int Care Med 1995; 21: 602–5.
  • Young B, Gleeson M, Cripps A. C-reactive protein: a critical review. Pathology 1991; 23: 118— 24.
  • Hansen J-ES, Larsen VA, Bog-Hansen TC. The microheterogeneity of alpha-l-acid glycoprotein in inflammatory lung disease, cancer of the lung and normal health. Clin Chim Acta 1984; 138: 41–7.
  • Mackiewicz A, Ganapathi MK, Schultz D, Kushner I. Monokines regulate glycosylation of acute-phase protein. J Exp Med 1987; 166: 253–8.
  • Fassbender K, Gerber B, Karrer U, Sobieska M, Aeschlimann A, Miller W. Glycosylation of acute phase proteins and interleukins following hip arthroplasty. Acta Arthop Scand 1993; 64: 216–20.
  • De Beer FC, Shine B, Pepys MB. Radiometric ligand binding assay for C-reactive protein. Complexed C-reactive protein is not detectable in acute phase serum. Clin Exp Immunol 1982; 50: 231–7.
  • De Beer FC, Soutar AK, Baltz ML, Trayner IM, Feinstein A, Pepys MB. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med 1982; 156: 230–42.
  • Tsujimoto M, Inone K, Nojima S. Purification and characterization of human serum C-reactive protein. J Biochem 1983; 94: 1367–73.
  • Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29 Suppl 124: 21–37.
  • Ganrot PO. Crossed immunoelectrophoresis. Scand J Clin Lab Invest 1972; 29 Suppl 124: 39–47.
  • Hames BD, Richwoud D, editors. Gel electro-phoresis of proteins. A practical approach. London, Washington: IRL Press, 1987
  • Towbin H, Staehelin T, Gordin J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applica-tions. Proc Natl Acad Sci USA 1979; 76: 4350–4.
  • Kindmark KO. Identification of C-reactive protein by agarose gel electrophoresis of human serum and plasma. Clin Chim Acta 1971; 35: 491–2.
  • Kindmark KO. Quantitative measurement of C-reactive protein in serum. Clin Chim Acta 1969; 26: 95–8.
  • Kolb-Bachofen V. A review on the biological properties of C-reactive protein. Immunobiology 1991; 183: 133–45.
  • Robey FA, Ohura K, Futaki S, Fujii N, Yajima H, Goldman N, Jones KD, Wahl S. Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity. J Biol Chem 1987; 262: 7053–7.
  • Bray RA, Samberg NL, Gewurz H, Potempa LA, Landay AL. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. J Immunol 1988; 140: 4271–8.
  • Fernandez MC, Mullenix MC, Christner RB, Mortensen RF. A cell attachment peptide from human C-reactive protein. J Cell Biochem 1992; 50: 83–92.
  • Gewurz H, Zhang XH, Lint TF. Structure and function of the pentaxins. Curr Opin Immunol 1995; 7: 54–64.
  • Potempa LA, Zeller JM, Fiedel BA, Kinoshita CM, Gewurz H. Stimulation of human neutro-phils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity. Inflammation 1988; 12: 391–405.
  • Shepard EG, Anderson R, Rosen 0, Myer MS, Fridkin M, Strachan AF, de Beer F. Peptides generated from C-reactive protein by a neutrophil membrane protease. J Immunol 1990; 145: 1469 — 76.
  • Shephard EG, Kelly SL, Anderson R, Fridkin M. Characterization of neutrophil-mediated degrada-tion of human C-reactive protein and identifica-tion of the protease. Clin Exp Immunol 1992; 87: 509— 13.
  • Mookerjea S, Francis J, Hunt D, Yong Yang C, Nagpurkar A. Rat C-reactive protein causes a charge modification of LDL and stimulates its degradation by macrophages. Arterioscler Thromb 1994; 14: 282–7.
  • Shields MJ. A hypothesis resolving the apparently disparate activities of native and altered forms of human C-reactive protein. Immunol Res 1993; 12: 37 — 47.
  • Köttgen E, Hell B, Kage A, Tauber R. Lectin specificity and binding characteristics of human C-reactive protein. J Immunol 1992; 149: 445–53.
  • Bleasby AJ, Knowles JC, Cooke NJ. Microhetero-geneity of a-l-acid glycoprotein: lack of discrimi-nation between benign and malignant inflamma-tory disease of the lung. Clin Chim Acta 1985; 150: 231–5.
  • Hansen J-ES, Jensen SP, Nörgaard-Pedersen B, B6g-Hansen T. Electrophoretic analysis of the glycan microheterogeneity of orosomuciod in cancer and inflammation. Electrophoresis 1986; 7: 180–3.
  • Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radio-iodinated human C-reactive protein in health and disease. J Clin Invest 1993; 90: 1351–7.
  • Appel RD, Sanchez JC, Bairoch A, Golaz 0, Miu M, Vargas JR, Hochstrasser DF. A database of two-dimensional gel electrophoresis images. Electrophoresis 1993; 14: 1232–8.
  • Pluschke G, Jenni L, Van Alpen L, Lefkovits I. Complete two-dimensional gel electrophoresis pattern of de novo synthesized acute phase reactant. Clin Exp Immunol 1986; 66: 331–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.